drugset / Trial / NCT05850702

Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine

NCT05850702 ↗

Phase 4 Unknown 92 enrolled RenJi Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The goal of this clinical trial is to test the effect of nebulized lidocaine on the hemodynamic response in the participant undergoing double-lumen endotracheal intubation. The main question it aims to answer is to evaluate the changes in mean arterial pressure after intubation. Participants will inhale 5ml of 2% lidocaine by nebulization15min before intubation. Researchers will compare saline group to see if saline effects

Timeline

Start
2023-06-15
Primary completion
2025-03-09
Completion
2025-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Inhaled
Subject Lidocaine Other / unclassified 5 ml Inhaled

Indications